Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

William J Watkins

Showing results (11-20 of 48) with videos related to

Pageof 5
Sort By:
Pediatrics|November 20, 2013
Gestational age, birth weight, and risk of respiratory hospital admission in childhoodShantini Paranjothy, Frank Dunstan, William J Watkins, et al.
Paediatric and Perinatal Epidemiology|March 5, 2021
Comparison of stillbirth trends over two decades in Wales, United Kingdom and Western Australia: An international retrospective cohort studyHelen D Bailey, Sarah J Kotecha, William J Watkins, et al.
Antimicrobial Agents and Chemotherapy|June 25, 2003
Molecular basis for fungal selectivity of novel antimitotic compoundsThomas Lila, Thomas E Renau, Lori Wilson, et al.
Kidney International Reports|May 2, 2022
Thymoglobulin Versus Alemtuzumab Versus Basiliximab Kidney Transplantation From Donors After Circulatory DeathArgiris Asderakis, Tarique K Sabah, William J Watkins, et al.
Bioorganic & Medicinal Chemistry Letters|June 6, 2012
Tri-substituted acylhydrazines as tertiary amide bioisosteres: HCV NS5B polymerase inhibitorsEda Canales, Joseph S Carlson, Todd Appleby, et al.
Archives of Disease in Childhood. Fetal and Neonatal Edition|October 23, 2015
Pulmonary arterial response to hypoxia in survivors of chronic lung disease of prematurityChuen Y Poon, William J Watkins, C John Evans, et al.
Bioorganic & Medicinal Chemistry|November 18, 2005
MexAB-OprM specific efflux pump inhibitors in Pseudomonas aeruginosa. Part 5: Carbon-substituted analogues at the C-2 positionKen-ichi Yoshida, Kiyoshi Nakayama, Noriko Kuru, et al.
Bioorganic & Medicinal Chemistry|September 19, 2006
MexAB-OprM specific efflux pump inhibitors in Pseudomonas aeruginosa. Part 6: exploration of aromatic substituentsKen-ichi Yoshida, Kiyoshi Nakayama, Yoshihiro Yokomizo, et al.
Bioorganic & Medicinal Chemistry Letters|September 24, 2004
Quinazolinone-based fungal efflux pump inhibitors. Part 1: Discovery of an (N-methylpiperazine)-containing derivative with activity in clinically relevant Candida sppRémy C Lemoine, Tomasz W Glinka, William J Watkins, et al.
Antimicrobial Agents and Chemotherapy|April 6, 2011
Structural and binding analysis of pyrimidinol carboxylic acid and N-hydroxy quinazolinedione HIV-1 RNase H inhibitorsEric B Lansdon, Qi Liu, Stephanie A Leavitt, et al.
Pageof 5

Showing results (11-20 of 48) with videos related to

Sort By:
Pageof 5
Pediatrics|November 20, 2013
Gestational age, birth weight, and risk of respiratory hospital admission in childhoodShantini Paranjothy, Frank Dunstan, William J Watkins, et al.
Paediatric and Perinatal Epidemiology|March 5, 2021
Comparison of stillbirth trends over two decades in Wales, United Kingdom and Western Australia: An international retrospective cohort studyHelen D Bailey, Sarah J Kotecha, William J Watkins, et al.
Antimicrobial Agents and Chemotherapy|June 25, 2003
Molecular basis for fungal selectivity of novel antimitotic compoundsThomas Lila, Thomas E Renau, Lori Wilson, et al.
Kidney International Reports|May 2, 2022
Thymoglobulin Versus Alemtuzumab Versus Basiliximab Kidney Transplantation From Donors After Circulatory DeathArgiris Asderakis, Tarique K Sabah, William J Watkins, et al.
Bioorganic & Medicinal Chemistry Letters|June 6, 2012
Tri-substituted acylhydrazines as tertiary amide bioisosteres: HCV NS5B polymerase inhibitorsEda Canales, Joseph S Carlson, Todd Appleby, et al.
Archives of Disease in Childhood. Fetal and Neonatal Edition|October 23, 2015
Pulmonary arterial response to hypoxia in survivors of chronic lung disease of prematurityChuen Y Poon, William J Watkins, C John Evans, et al.
Bioorganic & Medicinal Chemistry|November 18, 2005
MexAB-OprM specific efflux pump inhibitors in Pseudomonas aeruginosa. Part 5: Carbon-substituted analogues at the C-2 positionKen-ichi Yoshida, Kiyoshi Nakayama, Noriko Kuru, et al.
Bioorganic & Medicinal Chemistry|September 19, 2006
MexAB-OprM specific efflux pump inhibitors in Pseudomonas aeruginosa. Part 6: exploration of aromatic substituentsKen-ichi Yoshida, Kiyoshi Nakayama, Yoshihiro Yokomizo, et al.
Bioorganic & Medicinal Chemistry Letters|September 24, 2004
Quinazolinone-based fungal efflux pump inhibitors. Part 1: Discovery of an (N-methylpiperazine)-containing derivative with activity in clinically relevant Candida sppRémy C Lemoine, Tomasz W Glinka, William J Watkins, et al.
Antimicrobial Agents and Chemotherapy|April 6, 2011
Structural and binding analysis of pyrimidinol carboxylic acid and N-hydroxy quinazolinedione HIV-1 RNase H inhibitorsEric B Lansdon, Qi Liu, Stephanie A Leavitt, et al.
Pageof 5